Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5.
Mingxuan LiYutao ShenYujia XiongShuai WangChuzhong LiJiwei BaiYazhuo ZhangPublished in: Cell proliferation (2021)
Taken together, our results revealed that the SMARCB1/ATG5 axis is a promising therapeutic target for chordoma and autophagy inhibitors may be effective agents for chordoma treatment.